Nancy Yu is a pharmaceutical industry and financial analyst at the Center for Health Policy and Outcomes at Memorial Sloan Kettering Cancer Center in New York City.
Recent Posts by Nancy Yu
Recently we published a Health Affairs Blog post refuting the pharmaceutical industry argument that higher US prices are necessary to support R&D. While we appreciate the responses from Grabowski and Manning and from Light, we think they may have misunderstood our analysis.
The pharmaceutical industry often explains that the higher prices they charge in the US provide them with the funds they need to conduct their high-risk research. This claim is empirically testable.